Published in J Appl Genet on January 01, 2006
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett (2008) 2.28
Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta (2010) 1.29
The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation. BMC Genomics (2006) 1.17
Sequencing strategy for the whole mitochondrial genome resulting in high quality sequences. BMC Genomics (2009) 1.11
External contamination in single cell mtDNA analysis. PLoS One (2007) 1.04
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men. Prostate (2009) 0.92
The role of the mitochondrial genome in ageing and carcinogenesis. J Aging Res (2011) 0.90
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort. Blood (2014) 0.87
Real-time PCR analysis of a 3895 bp mitochondrial DNA deletion in nonmelanoma skin cancer and its use as a quantitative marker for sunlight exposure in human skin. Br J Cancer (2006) 0.87
Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'? J Biomed Sci (2010) 0.85
Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies. PLoS One (2013) 0.84
Common mitochondrial polymorphisms as risk factor for endometrial cancer. Int Arch Med (2009) 0.83
Regulation of metastasis; mitochondrial DNA mutations have appeared on stage. J Bioenerg Biomembr (2012) 0.82
Mitochondria and cancer. Virchows Arch (2009) 0.81
Mitochondrial DNA 4977 bp Deletion in Chronic Cervicitis and Cervix Cancers. Balkan J Med Genet (2012) 0.79
Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival. Cancer Inform (2015) 0.78
Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer. BMC Cancer (2008) 0.77
Mitochondrial dysfunction in cancer. Prz Menopauzalny (2014) 0.77
Trading mtDNA uncovers its role in metastasis. Cell Adh Migr (2009) 0.77
Mitochondrial genotype in vulvar carcinoma - cuckoo in the nest. J Biomed Sci (2010) 0.75
Identification of additional mitochondrial DNA mutations in canine mast cell tumours. Acta Vet Scand (2016) 0.75
Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A (2002) 6.95
The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway. EMBO J (2013) 1.61
Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet (2004) 1.49
Investigation of a pathogenic mtDNA microdeletion reveals a translation-dependent deadenylation decay pathway in human mitochondria. Hum Mol Genet (2003) 1.42
Human mitochondrial RNA turnover caught in flagranti: involvement of hSuv3p helicase in RNA surveillance. Nucleic Acids Res (2009) 1.25
Localisation of the human hSuv3p helicase in the mitochondrial matrix and its preferential unwinding of dsDNA. Nucleic Acids Res (2002) 1.20
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat (2009) 1.05
Differential stability of mitochondrial mRNA in HeLa cells. Acta Biochim Pol (2005) 1.04
In vitro reconstitution and characterization of the yeast mitochondrial degradosome complex unravels tight functional interdependence. J Mol Biol (2007) 0.99
Revisiting the yeast PPR proteins--application of an Iterative Hidden Markov Model algorithm reveals new members of the rapidly evolving family. Mol Biol Evol (2011) 0.99
Balance between transcription and RNA degradation is vital for Saccharomyces cerevisiae mitochondria: reduced transcription rescues the phenotype of deficient RNA degradation. Mol Biol Cell (2005) 0.95
Maintenance and expression of the S. cerevisiae mitochondrial genome--from genetics to evolution and systems biology. Biochim Biophys Acta (2010) 0.94
MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: coordinate regulation of OXPHOS, antioxidant, and apoptotic genes. Biochim Biophys Acta (2008) 0.93
Interaction of human SUV3 RNA/DNA helicase with BLM helicase; loss of the SUV3 gene results in mouse embryonic lethality. Mech Ageing Dev (2007) 0.93
Mitochondrial encephalopathy in a patient with a 13042G>A de novo mutation. J Clin Pathol (2012) 0.91
Down-regulation of human RNA/DNA helicase SUV3 induces apoptosis by a caspase- and AIF-dependent pathway. Biol Cell (2007) 0.90
The role of the mitochondrial genome in ageing and carcinogenesis. J Aging Res (2011) 0.90
DMR1 (CCM1/YGR150C) of Saccharomyces cerevisiae encodes an RNA-binding protein from the pentatricopeptide repeat family required for the maintenance of the mitochondrial 15S ribosomal RNA. Genetics (2010) 0.89
Genotype-phenotype correlations in Leber hereditary optic neuropathy. Biochim Biophys Acta (2010) 0.87
Comparison between the Polish population and European populations on the basis of mitochondrial morphs and haplogroups. Acta Biochim Pol (2004) 0.87
Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol (Noisy-le-grand) (2002) 0.86
Yeast and human mitochondrial helicases. Biochim Biophys Acta (2013) 0.86
Breast cancer as a mitochondrial disorder (Review). Oncol Rep (2009) 0.85
Two nuclear life cycle-regulated genes encode interchangeable subunits c of mitochondrial ATP synthase in Podospora anserina. Mol Biol Evol (2011) 0.85
Metalloid tolerance based on phytochelatins is not functionally equivalent to the arsenite transporter Acr3p. Biochem Biophys Res Commun (2003) 0.84
Nuclear and mitochondrial genome responses in HeLa cells treated with inhibitors of mitochondrial DNA expression. Acta Biochim Pol (2006) 0.84
Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion (2003) 0.82
Mitochondrial genotype and breast cancer predisposition. Oncol Rep (2010) 0.82
Bacterial diversity in Adélie penguin, Pygoscelis adeliae, guano: molecular and morpho-physiological approaches. FEMS Microbiol Ecol (2004) 0.81
Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep (2010) 0.81
Diversity of clinical symptoms in A3243G mitochondrial DNA mutation (MELAS syndrome mutation). Med Sci Monit (2002) 0.80
Arsenical resistance genes in Saccharomyces douglasii and other yeast species undergo rapid evolution involving genomic rearrangements and duplications. FEMS Yeast Res (2004) 0.80
Leber hereditary optic neuropathy--a disease with a known molecular basis but a mysterious mechanism of pathology. J Appl Genet (2003) 0.79
RNA degradation in yeast and human mitochondria. Biochim Biophys Acta (2011) 0.79
Mitochondrial DNA Polymerase γ Mutations and Their Implications in mtDNA Alterations in Colorectal Cancer. Ann Hum Genet (2015) 0.79
Mitochondrial cytopathies: clinical, morphological and genetic characteristics. Neurol Neurochir Pol (2009) 0.77
[The impact of mtDNA mutations on proteins structure in selected types of cancer]. Postepy Biochem (2008) 0.77
G8363A mitochondrial DNA mutation is not a rare cause of Leigh syndrome - clinical, biochemical and pathological study of an affected child. Folia Neuropathol (2007) 0.77
Yeast model analysis of novel polymerase gamma variants found in patients with autosomal recessive mitochondrial disease. Hum Genet (2015) 0.77
[Molecular biology of endometrial carcinoma]. Postepy Hig Med Dosw (Online) (2008) 0.77
Molecular investigations of mitochondrial deletions: evaluating the usefulness of different genetic tests. Gene (2012) 0.77
[Mitochondrial DNA mutations in the pathogenesis in the head and neck squamous cell carcinoma]. Otolaryngol Pol (2008) 0.77
In vivo and in vitro approaches for studying the yeast mitochondrial RNA degradosome complex. Methods Enzymol (2008) 0.77
Assays of the helicase, ATPase, and exoribonuclease activities of the yeast mitochondrial degradosome. Methods Mol Biol (2010) 0.77
Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer. BMC Cancer (2008) 0.77
A family with 3460G>A and 11778G>A mutations and haplogroup analysis of Polish Leber hereditary optic neuropathy patients. Mitochondrion (2008) 0.76
Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations. Oncol Rep (2006) 0.76
The role of the cell-cell interactions in cancer progression. J Cell Mol Med (2015) 0.75
Mitochondrial genotype in vulvar carcinoma - cuckoo in the nest. J Biomed Sci (2010) 0.75
In vivo analysis of the relationships between the splicing and homing activities of a group I intron-encoded I-ScaI/bi2-maturase of Saccharomyces capensis produced in the yeast cytoplasm. FEMS Yeast Res (2006) 0.75
[MELAS--mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome--two cases confirmed by biochemical and molecular investigations. Differential diagnosis of stroke causes]. Neurol Neurochir Pol (2002) 0.75
[Leber's hereditary optic neuropathy (LHON) with mutation at G3460A and MS-like phenotype]. Neurol Neurochir Pol (2003) 0.75
Heteroplasmy analysis in the Polish patients with 11778A mutation responsible for Leber hereditary optic neuropathy. Acta Biochim Pol (2002) 0.75
[The role of reactive oxygen species and mitochondria in aging]. Postepy Biochem (2014) 0.75
[A case or Leber hereditary optic neuropathy (LHON): differential diagnosis with post inflammatory atrophy of nerve II using the mtDNA analysis]. Neurol Neurochir Pol (2003) 0.75
[Nobel Prize in Physiology and Medicine 2001]. Neurol Neurochir Pol (2002) 0.75
Mitochondrial DNA in polish centenarians. Toxicol Mech Methods (2004) 0.75
Prediction of the structure of the common perimitochondrial localization signal of nuclear transcripts in yeast. Acta Biochim Pol (2007) 0.75
Mitochondrial DNA in tumors. Toxicol Mech Methods (2004) 0.75
Sex, death and the (nerve) cell. Front Biosci (Elite Ed) (2012) 0.75
[Clinical examination of Leber hereditary optic neuropathy in patients with the same gene mutation]. Przegl Lek (2002) 0.75